Literature DB >> 24859427

Cancer initiation with epistatic interactions between driver and passenger mutations.

Benedikt Bauer1, Reiner Siebert2, Arne Traulsen1.   

Abstract

We investigate the dynamics of cancer initiation in a mathematical model with one driver mutation and several passenger mutations. Our analysis is based on a multi-type branching process: we model individual cells which can either divide or undergo apoptosis. In the case of a cell division, the two daughter cells can mutate, which potentially confers a change in fitness to the cell. In contrast to previous models, the change in fitness induced by the driver mutation depends on the genetic context of the cell, in our case on the number of passenger mutations. The passenger mutations themselves have no or only a very small impact on the cell's fitness. While our model is not designed as a specific model for a particular cancer, the underlying idea is motivated by clinical and experimental observations in Burkitt Lymphoma. In this tumor, the hallmark mutation leads to deregulation of the MYC oncogene which increases the rate of apoptosis, but also the proliferation rate of cells. This increase in the rate of apoptosis hence needs to be overcome by mutations affecting apoptotic pathways, naturally leading to an epistatic fitness landscape. This model shows a very interesting dynamical behavior which is distinct from the dynamics of cancer initiation in the absence of epistasis. Since the driver mutation is deleterious to a cell with only a few passenger mutations, there is a period of stasis in the number of cells until a clone of cells with enough passenger mutations emerges. Only when the driver mutation occurs in one of those cells, the cell population starts to grow rapidly.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Modeling; Population dynamics; Somatic evolution

Mesh:

Year:  2014        PMID: 24859427     DOI: 10.1016/j.jtbi.2014.05.018

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  12 in total

Review 1.  A population genetics perspective on the determinants of intra-tumor heterogeneity.

Authors:  Zheng Hu; Ruping Sun; Christina Curtis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-06       Impact factor: 10.680

2.  Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution.

Authors:  Dominik Wodarz; Alan C Newell; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2018-06       Impact factor: 4.118

Review 3.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03

Review 4.  Somatic mosaicism: implications for disease and transmission genetics.

Authors:  Ian M Campbell; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2015-04-21       Impact factor: 11.639

Review 5.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

6.  Emergence of heterogeneity in acute leukemias.

Authors:  Thomas Stiehl; Christoph Lutz; Anna Marciniak-Czochra
Journal:  Biol Direct       Date:  2016-10-12       Impact factor: 4.540

7.  An exactly solvable, spatial model of mutation accumulation in cancer.

Authors:  Chay Paterson; Martin A Nowak; Bartlomiej Waclaw
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

8.  Repeatability of evolution on epistatic landscapes.

Authors:  Benedikt Bauer; Chaitanya S Gokhale
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

9.  Should tissue structure suppress or amplify selection to minimize cancer risk?

Authors:  Laura Hindersin; Benjamin Werner; David Dingli; Arne Traulsen
Journal:  Biol Direct       Date:  2016-08-23       Impact factor: 4.540

10.  Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model.

Authors:  Augusto Cabrera-Becerril; Cruz Vargas-De-León; Sergio Hernández; Pedro Miramontes; Raúl Peralta
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.